First d·Health Barcelona class of innovators

In 2014, the first class of health innovators graduated from Design Health Barcelona (d·HEALTH Barcelona), the first postgraduate biodesign program in the country, promoted by Biocat to foster innovation in health, entrepreneurial spirit and professional development in the biomedical arena.

d·HEALTH Barcelona is the flagship program of Moebio, an initiative mainly aimed at developing entrepreneurial talent in the health and life sciences sector. In the first edition, d·HEALTH Barcelona fellows identified nearly 1,200 new unmet clinical needs at Hospital Clínic Barcelona, Hospital Sant Joan de Déu and Institut Guttmann, the three healthcare centers that collaborated on the first edition of the program.

Of these ideas, 40% offered business opportunities and one of them is now a reality: usMIMA, a solution for people with spinal cord injuries to reduce chronic constipation. This company, set up in October 2014 by one of the three groups of fellows from the program, was also the winner of the BioEmprenedorXXI award, which recognizes the business projects in the life sciences sector with the greatest potential for growth.
The first edition of d·HEALTH Barcelona was made possible thanks to the support of organizations like the Agency for Management of University and Research Grants (AGAUR) and the Health University of Barcelona Campus (HUBc), as well as companies like Sanofi and Accenture

Successful first European Biomedical Investor Day

The first edition of d·HEALTH Barcelona officially came to a close in September at the first European Biomedical Investor Day, an event created to facilitate market access for innovative medical technology. The event, organized by Biocat and 6 institutions that are pioneers in this field around the world, was held at the Centre de Cultura Contemporània de Barcelona (CCCB) with participants from 10 biodesign programs from around the world.

The d·HEALTH Barcelona program was represented by usMIMA, a company founded by one of the teams from the program. Other participants included teams from BioInnovate Ireland (Ireland), the Center for Technology in Medicine and Health (Sweden), Inno X Healtcare (Denmark), Y-SIP, IHU-Strasbourg (France), Biodesign Israel (Israel) and Stanford Biodesign (California, USA), which presented their innovative solutions to a group of international investors, businesspeople, business administrators, politicians and healthcare professionals.

The winner was Torix Medical, a spin-off of the pioneering Stanford Biodesign program, which has created a minimally invasive device to permanently relieve urinary obstruction associated with benign prostatic hyperplasia. 

Second edition of d·HEALTH Barcelona

Taking over from the first class of innovators, a group of eight fellows began the second edition of d·HEALTH Barcelona in September 2014, doing clinical immersions to identify unmet clinical needs in obstetrics at Hospital Sant Joan de Déu Barcelona and gastrointestinal surgery at Hospital Clínic.

This immersion and the rest of the phases of the program are combined with classes, MOOCs and workshops given by more than 50 international experts, including Dan E. Azagury (Stanford University, USA), Yossi Bahagon (Clalit Health Services, Jerusalem), Chia Hwu (Qubop, Silicon Valley), David Maltz (Novartis, Silicon Valley) and Lekshmy Parameswaran (Fuelfor, Barcelona-Singapore). This edition of d·HEALTH Barcelona has once again received support from AGAUR, HUBc and Sanofi, as well as KaosPilot and the Ministry of Education, Culture and Sport. 

 

Graduation of the first fellow class of d·Health Barcelona

MOEBIO Short Programs: d·HEALTH Barcelona opens up to the public

New for the 2014-2015 school year, Biocat has opened up some of the d·HEALTH Barcelona sessions to the public. These are the MOEBIO Short Programs, educational programs lasting no more than 20 hours and covering key issues in healthcare, innovation, management and entrepreneurship.

The first of these programs, which will train professionals interested in broadening their skillset and acquiring new practical knowledge about the most pressing issues in technological innovation for health, kicked off in September 2014. The MOEBIO Short Programs aim to study trends and patterns in the healthcare sector and related industries and to understand healthcare organizations, provisions, regulations and funding, among other goals. They are designed especially for entrepreneurs, managers and executives at healthcare organizations, students, recent graduates, and other professionals interested in expanding their areas of expertise to healthcare and entrepreneurship.

MOEBIO Short Programs 2014-2015:

Understanding Healthcare Systems

Update on the pharmaceutical & Biotecnology Industry

Medical Devices

The future of Healthcare

X-Thinking Skills

New Business Models in Healthcare

Entrepreneurship and Management